Clinical Trials for GV20 Therapeutics

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: GV20 Therapeutics

Clinical Trials (3)

NCT07106827
A Study of GV20-0251 in Advanced or Refractory Solid Tumors
PHASE1Not yet recruiting
10 participants
Started: Jul 31, 2025 · Completed: Jun 11, 2028
8 conditions2 sponsors1 location
NCT07070518
Study of GV20-0251 in Participants With Solid Tumor Malignancies
PHASE1/PHASE2Recruiting
350 participants
Started: Jul 11, 2025 · Completed: Sep 16, 2028
9 conditions1 sponsor1 location
NCT05669430
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
PHASE1/PHASE2Recruiting
365 participants
Started: Mar 23, 2023 · Completed: Sep 5, 2027
7 conditions2 sponsors13 locations